Invention Application
- Patent Title: 7-SITE SUBSTITUTED PYRROLE TRIAZINE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND PREPARATION METHOD THEREOF AND USES THEREOF
-
Application No.: US16626254Application Date: 2018-06-22
-
Publication No.: US20200157110A1Publication Date: 2020-05-21
- Inventor: Chunhao YANG , Linghua MENG , Haoyue XIANG , Jing LI , Xi ZHANG , Xiang WANG , Cun TAN , Qian HE , Jian DING , Yi CHEN
- Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7565e1c8
- International Application: PCT/CN2018/092419 WO 20180622
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00

Abstract:
The present disclosure relates to 7-substituted pyrrolo[2,1-f][1,2,4]triazine compounds or pharmaceutically acceptable salts thereof, and preparation methods and uses thereof. These compounds show good PI3K inhibitory activity, can effectively inhibit the activity of PI3K kinase, and has significant enhancement and improvement of pharmacokinetic properties, such as bioavailability, due to the introduction of the 7-position group; furthermore, the compounds of the present disclosure exhibit an unpredictable high selectivity and strong inhibitory activity on PI3Kδ, and thus these compounds can be used for treating diseases related to PI3K pathway, especially for anti-cancer or for the treatment of tumors, leukemias and autoimmune diseases. After further optimizing and screening, the compounds are expected to be developed into a new type of anti-tumor drugs.
Public/Granted literature
Information query